These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4476720)

  • 21. [Highly purified insulins in the modern treatment of diabetes].
    Woenckhaus JW
    Med Klin; 1975 Sep; 70(36):1401-7. PubMed ID: 1101007
    [No Abstract]   [Full Text] [Related]  

  • 22. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment with monocomponent semi-lente insulin in diabetes of difficult compensation].
    Barbero L; Gamba S; Zanno C; Regis G; Bruni B
    Minerva Med; 1978 Apr; 69(21):1437-42. PubMed ID: 683547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 25. [Monocomponent insulin: general considerations].
    Rodriguez-Miñon JL; Rios MS
    Journ Annu Diabetol Hotel Dieu; 1978; ():109-22. PubMed ID: 651088
    [No Abstract]   [Full Text] [Related]  

  • 26. [Purity and antigenicity of the new insulin preparations].
    Fankhauser S
    Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin antibodies in diabetes.
    Lev-Ran A; Joshua H; Mannheimer S
    Isr J Med Sci; 1971 Sep; 7(9):1035-9. PubMed ID: 5170197
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating antibodies in diabetics treated with conventional and purified insulins.
    Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
    S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of high-purity insulins in the treatment of patients with diabetes mellitus].
    Spesivtseva VG; Pokryshkin VI; Belokrinitskiĭ ; Koroleva TV; Mamaeva GG
    Ter Arkh; 1987; 59(11):22-6. PubMed ID: 3327181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
    Bemm H; Lohmann D
    Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 32. Monocomponent insulin in maturity onset diabetes mellitus.
    Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M
    J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diabetes mellitus. 13. Insulin therapy of diabetes mellitus].
    Michaelis D
    Z Arztl Fortbild (Jena); 1971 Oct; 65(20):1006-13. PubMed ID: 5170112
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin antibody formation. II. The influence of species difference and method of administration.
    Andersen OO
    Acta Endocrinol (Copenh); 1973 Jan; 72(1):33-45. PubMed ID: 4739228
    [No Abstract]   [Full Text] [Related]  

  • 35. [The antigenicity of various new chromatographically purified depot insulin preparations].
    Graber D; Fankhauser S
    Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
    Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
    Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of highly purified Iletin-II-type porcine insulins and human insulin preparations in clinical practice].
    Petunina NA; Balabolkin MI; Mkrtumian AM; Sergeev AV; Nedosugova LV
    Ter Arkh; 1993; 65(10):29-31. PubMed ID: 8296229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
    Yue DK; Turtle JR
    Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Initial treatment and prognosis of diabetes mellitus].
    Lohmann D; Kunze U; Schüritz P; Steltz G
    Dtsch Gesundheitsw; 1969 Feb; 24(7):296-301. PubMed ID: 5386441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.